William Rosellini

William Rosellini is the President of CytoImmune Therapeutics, Inc, a clinical stage biotechnology company. Previously, Rosellini was the CEO of Perimeter Medical, Inc. (TSX:V "PINK") where he oversaw 2 510K clearances, an RTO and $30M in capital raised. Prior to that he was the CEO Nexeon Medsystems, Inc., ("OTC:QB, NXNN")a medical device manufacturing company that went public in 2017. Before that he founded, raised $16M across A/B rounds and led Lexington Technology Group, LLC, a database company commercializing an electronic health record database solution to an exit ("DSS" NYSE). Before that he founded Sarif Biomedical LLC, a stereotactic cancer microsurgery with IP spun-out of Medtronic and led company to an exit with Marathon Patent Group, Inc. ("MARA" NSDQ). Rosellini is driven to help founders and inventors with game-changing ideas overcome business, legal, and financial obstacles toward achieving widespread market adoption. Let’s connect!

• Details
• 2 posts
• https://williamrosellini.com/
• Female
• 11-30--1
• Living in United States
• Located in USA